Dr. Ruben Mesa and Dr. Robyn Scherber hematologists from the Mays Cancer Center, home to UT Health San Antonio MD Anderson discuss the latest updates regarding new treatments for myeloproliferative neoplasms (MPNS) including essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF). They also discuss the latest updates from the 2019 American Society of Hematology Annual Meeting.